Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7306 p7
3 July 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Women unsure which pill they are taking

Almost half of women taking the oral contraceptive pill are not sure which type of pill they are taking. This is a finding from a recent MORI social research institute survey commissioned by Brook Advisory Centres.

Of 682 women aged 16–55 years surveyed, 23 per cent reported taking the contraceptive pill, but 43 per cent of these were not sure whether it was the combined pill or the progestogen-only pill (POP). Most POPs need to be taken within three hours of the specified time to remain effective, compared with 12 hours for combined pills, so women who are unaware which type of pill they are taking may risk unplanned pregnancy. The survey also showed that less than half of women taking the contraceptive pill felt they were given adequate choice in their selection of their pill.

The study was funded by Organon Laboratories. At the same time, Organon has announced that the “missed pill window” for its POP Cerazette (desogestrel) has been extended, following new evidence that it consistently inhibits ovulation even when tablets are taken 12 hours late. Cerazette may now be taken up to 12 hours after the specified time without compromising contraceptive protection. Organon says that Cerezette is the first oestrogen-free pill to inhibit ovulation to the same extent as a combined pill.


Notice-board p11

Back to Top


©The Pharmaceutical Journal